Navigation Links
Beacon Announces Agreement With New Fortune 500 Pharmaceutical Client
Date:4/14/2011

LOUISVILLE, Ky., April 14, 2011 /PRNewswire/ -- Beacon Enterprise Solutions Group, Inc. (OTC BB:  BEAC) (www.askbeacon.com), an emerging global leader in the design, implementation and management of high performance Information Technology Systems (ITS), today announces the signing of a third US-based Fortune 500 global pharmaceutical client.

(Logo:  http://photos.prnewswire.com/prnh/20101021/DA85933LOGO)

Beacon has been selected by this global pharmaceutical client to provide planning, design and engineering services for its global data center.  Although the name of this client and exact project details are confidential at the request of the client, this new agreement represents further penetration within the Pharmaceutical vertical market by Beacon.  This project will utilize Beacon's data center design expertise relating to ITS infrastructure, data equipment and mechanical / electrical systems.  Beacon is expected to complete this project in the late third quarter of this fiscal year, which ends September 30, 2011.

"The signing of another Fortune 500 client is the beginning of new growth and momentum for our company, following our decision last year to refocus on our core business," stated Bruce Widener, Chairman and CEO of Beacon.  "Our success with other large companies in the pharmaceutical vertical allows Beacon to leverage our core expertise for ITS services and drive revenue in this vertical market segment where we expect increased activity in fiscal 2011."

"The medical and pharmaceutical industries contain a high-density of sophisticated technology systems, which historically have been serviced by a patchwork quilt of local and regional services firms," stated Jerry Bowman, President and COO of Beacon.  "Beacon has a demonstrated history of providing clear value and market leadership by assisting global and multi-national companies in providing standardized delivery of complex ITS infrastructure wherever they need it, not just where we already happen to have an office.  We know this space well and adding another US-based pharmaceutical client of this size is the first of several major new clients expected to be announced this fiscal year.  We look forward to working with this new client and expect to follow the trend established with our other pharmaceutical clients and develop a long-term relationship."

About Beacon Enterprise Solutions Group, Inc.

Beacon Enterprise Solutions Group is an emerging global leader in the design, implementation and management of high performance Information Technology Systems ("ITS") infrastructure solutions.  Beacon offers fully integrated, turnkey IT infrastructure solutions capable of fully servicing the largest companies in the world as they increasingly outsource to reduce costs while optimizing critical IT design and infrastructure management. Beacon is headquartered in Louisville, Kentucky, with a regional headquarters in Dublin, Ireland, Prague, Czech Republic and personnel located throughout the United States and Europe.

For additional information, please visit Beacon's corporate website: www.askbeacon.com

This press release may contain "forward-looking statements." Expressions of future goals and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements.  These forward-looking statements may include, without limitation, statements about our market opportunity, strategies, competition, expected activities and expenditures as we pursue our business plan.  Although we believe that the expectations reflected in any forward looking statements are reasonable, we cannot predict the effect that market conditions, customer acceptance of products, regulatory issues, competitive factors, or other business circumstances and factors described in our filings with the Securities and Exchange Commission may have on our results.  The company undertakes no obligation to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this press release.

Contact:
Bruce Widener, CEO
502-657-3507
investors@askbeacon.com

Porter, LeVay & Rose, Inc.
Marlon Nurse, V.P. – Investor Relations
212-564-4700

Halliburton Investor Relations
Geralyn DeBusk, President, or HalaElsherbini, COO
972-458-8000


'/>"/>
SOURCE Beacon Enterprise Solutions Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Researchers Use Nanoparticles as Destructive Beacons to Zap Tumors
2. IDEV Announces Full Canadian Regulatory Approval for SUPERA VERITAS®
3. Solta Medical Announces First Quarter 2011 Results Release and Conference Call
4. Amgen Announces Webcast of 2011 First Quarter Financial Results
5. Award Winning Vascular Imaging Device Company Announces New Patents
6. ThermoGenesis Announces Registration of Res-Q in India; Commercial Sales Expected to Begin in Current Quarter
7. Medco Announces Date for Release of First-Quarter 2011 Financial Results
8. BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
9. Life Technologies Announces an Automated Sample Preparation System for its Ion PGM™ Sequencer
10. Marinus Pharmaceuticals Announces U.S. Department of Defense Grant to Study Ganaxolone in Fragile-X Syndrome
11. Perrigo Announces Conclusion of the FDA Re-Inspection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
(Date:6/24/2016)... ... 24, 2016 , ... Puradigm® & Innovative Solutions today announced ... and processing operations at its production facility, and opened its first two dispensaries ... manufacturer of a complete system of proactive air and surface purification solutions for ...
Breaking Medicine News(10 mins):